Core Viewpoint - Jyong Biotech Ltd. is experiencing fluctuations in its share price and increased trading volume following the expiry of the lock-up period, while engaging with investment funds interested in purchasing its shares [1]. Company Overview - Jyong Biotech Ltd. is a biotechnology company based in Taiwan, focused on developing and commercializing innovative plant-derived drugs, particularly for urinary system diseases, with a target market in the U.S., EU, and Asia [6]. - The company has established integrated capabilities across all key functionalities of drug development since its inception in 2002, including drug discovery, clinical trials, and commercialization [6]. Financial and Operational Status - The company's research and development operations remain solid, and its financial condition is consistent with recent public filings, including the Current Report on Form 6-K [3]. - Jyong Biotech has completed four Phase III clinical trials in the U.S. and Taiwan, along with one Phase II clinical trial in Taiwan, and is advancing its investigational pipeline [5]. Strategic Developments - The company holds global multi-country invention patents, providing market protection across the Americas, Asia, and Europe, and has signed Letters of Intent (LOIs) with several international pharmaceutical companies [5]. - Jyong Biotech is committed to expanding its global presence and aims to deliver world-class botanical new drugs to address significant unmet medical needs [5]. Compliance and Disclosure - The company confirms compliance with SEC regulations and is not aware of any material, unpublished price-sensitive information that would explain the recent trading activity [2][4].

As filed with the Securities and Exchange Commission on October 31, 2024 Registration Statement No. 333-277725 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 6 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Fang Liu, Esq. VCL Law LLP 1945 Old Gallows Road, Suite 260 Vienna, VA 22182 Tel: 703-919-7285 Approximate date of commencement of proposed sale to the public: as soon as practicable after the effective date of this registration statement. ________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 5 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ____________________________ Jyong Biotech Ltd. As filed with the Securities and Exchange Commission on October 4, 2024 Registration Statement No. 333-277725 If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐ (Exact name o ...

As filed with the Securities and Exchange Commission on September 13, 2024 Registration Statement No. 333-277725 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 4 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ____________________________ Jyong Biotech Ltd. (Exact name of Registrant as specified in its charter) ____________________________ Not Applicable (Translation of Registrant's name into English) | Cayman Islands | 2834 | Not Applicable | | --- | ...

As filed with the Securities and Exchange Commission on August 2, 2024 Registration Statement No. 333-277725 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 3 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ____________________________ Jyong Biotech Ltd. (Exact name of Registrant as specified in its charter) ____________________________ Not Applicable (Translation of Registrant's name into English) Fang Liu, Esq. VCL Law LLP 1945 Old Gallows Road, Suite ...

As filed with the Securities and Exchange Commission on May 8, 2024 Registration Statement No. 333-277725 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ____________________________ Jyong Biotech Ltd. (Exact name of Registrant as specified in its charter) ____________________________ Not Applicable (Translation of Registrant's name into English) | Cayman Islands | 2834 | Not Applicable | | --- | --- | - ...